Aurora Bolsters Anandia’s Testing Capabilities By means of Acquisition of Chemi Pharmaceutical

[ad_1]

 Aurora Cannabis Inc. announced nowadays that the enterprise has signed a binding share acquire agreement whereby Aurora has acquired all of the issued and outstanding prevalent shares of privately-held Chemi Pharmaceutical Inc, an Ontario-primarily based laboratory specialized in giving higher excellent analytics solutions to the pharmaceutical and cannabis industries, in a money and share transaction comprised of an undisclosed money payment and share consideration of 83,299 shares paid on closing and 41,649 payable upon achievement of specific Chemi milestones.

Strategic Rationale

Chemi has a Wellness Canada Drug Establishment Licence enabling them to execute certified GMP compliant excellent manage analytical testing. In addition, Chemi has received US FDA accreditation for their facility, which is the gold common for worldwide pharmaceutical testing. Acquiring Chemi with their Drug Establishment Licence gives a essential prerequisite for applying for a Cannabis Drug Licence, which is needed for the improvement of cannabis therapies inside the worldwide healthcare cannabis market place.

Strategically positioned adjacent to Pearson Airport in Mississauga, Ontario, Chemi gives specialized cannabis testing across a broad set of parameters, like cannabinoid and terpene content material. Chemi will be integrated into the Company’s wholly owned subsidiary, Anandia Laboratories Inc. (

View the Original short article

[ad_2]

Latest posts